· Executive Brief
COPD Awareness Month 2026
A practical executive framework for access, ownership, handoffs, measurement, and improvement.
Leadership signal
COPD Awareness Month can serve as an executive operating checkpoint.
Awareness can generate questions and requests for help. Executive teams can prepare by clarifying the first point of contact, the qualified team that accepts the request, the handoff standard, and the method used to verify completion without assuming that one route fits every person.
Start by distinguishing what is known from what the organization still needs to learn. A campaign plan, communication volume, or meeting count does not establish that a route is usable. Leaders need direct listening, clear ownership, locally defined measures, and a method for keeping exceptions visible.
Executive opening
COPD care is a chain of handoffs that leaders can strengthen
COPD Awareness Month arrives as the burden of chronic lung disease keeps shifting across hospitals, clinics, homes and health plans. Among U.S. adults aged 65 and older, the age-adjusted mortality rate for deaths involving both atrial fibrillation and COPD rose from 27.39 in 1999 to 65.29 in 2020.[12] Deaths involving COPD and obesity show a similar climb, from 0.78 per 100,000 in 1999 to 2.63 per 100,000 in 2023.[14] These are population trends rather than forecasts for any one organization. They still describe a patient group that is older, more complex and more often managed outside the hospital.
The operating question is whether the care pathway holds together between those settings. A meta-analysis of 54 studies reported pooled COPD-related readmission rates of 15.2% within one month and 42.10% within one year after discharge.[4] In the United Kingdom, only 40% of eligible patients are referred to pulmonary rehabilitation, despite strong evidence of benefit.[5] Each of these figures reflects a step that depends on someone ordering, explaining, scheduling or following up. When any one of those people is missing, the patient usually experiences the gap before the organization measures it.
Basic elements of care also vary. In a national veterans cohort of 882,292 people with COPD, both women and men experienced suboptimal receipt of guideline-recommended care, including confirmatory spirometry, maintenance inhalers and tobacco cessation support.[3] Inhaler technique is a related weak point. At the start of a phone-based education program, 39.4% of Medicare Advantage participants were using their inhalers incorrectly.[2] Some subgroups were at greater risk of misuse both before and after training.[2]
The sections that follow summarize recent peer-reviewed evidence on diagnosis, inhaler education, rehabilitation uptake, transitions after hospitalization, equity, workforce and communication. They sit alongside the executive guidance already on this page. Together they give leaders a shared factual base for choosing which COPD handoff to strengthen first.
Current evidence
What recent research shows about COPD burden and care gaps
COPD increasingly appears alongside other chronic conditions, which complicates both care and measurement. The national analysis of deaths involving atrial fibrillation and COPD recorded 399,413 deaths, and the most common place of death shifted from medical facilities to home by 2020.[12] COPD, ischemic heart disease and cancer were the leading cause-of-death categories in that analysis.[12] The authors projected that the age-adjusted mortality rate would reach 92.62 by 2030, with the largest increase among people aged 85 and older.[12]
Neurological and metabolic conditions add further complexity. One analysis examined 58,495 deaths involving COPD and Alzheimer’s disease among U.S. adults older than 55.[13] Age-adjusted mortality rose from 2.04 per 100,000 in 1999 to 5.19 per 100,000 in 2020.[13] For deaths involving COPD and obesity, the average annual percent change was +5.14% from 1999 to 2023, with an increase during the COVID-19 pandemic.[14] That rate rose markedly during 2018 to 2021 (annual percent change +17.45%) and then declined significantly through 2023.[14] Males and adults aged 65 and older carried higher mortality burdens.[14] The authors stressed that population-level associations do not establish causality.[14]
Prevention signals point back to tobacco and social conditions. In a national survey analysis covering 2020 to 2024, coexisting coronary heart disease and COPD had a stable adjusted prevalence of approximately 0.35% to 0.43% a year among U.S. adults.[15] Smoking, older age, male sex, lower income and Southern residence were the strongest independent predictors.[15] The authors called for prevention strategies that address tobacco use across vulnerable populations.[15]
Gaps in care delivery begin with diagnosis. In the veterans cohort, women made up 34,645 of 882,292 people with COPD, or 3.9%.[3] After age matching, women had higher odds of confirmatory spirometry (adjusted odds ratio 1.24) and tobacco cessation intervention (1.23), but lower odds of a maintenance inhaler prescription (0.86).[3] The authors concluded that receipt of guideline-recommended care was suboptimal for both sexes.[3]
Readmission risk keeps accumulating after the first month. Pooled rates rose from 15.2% at one month to 26.90% at three months, 30.40% at six months and 42.10% at one year.[4] The same review identified 26 factors associated with readmission, and the methodological quality of the included studies was moderate to high.[4] For executives, that pattern argues for tracking follow-through well beyond the standard 30-day window.
Figure 1
Where COPD pathways leak
Percent of patients, physicians or eligible people at a pathway step, as reported in each study. Values are copied from the cited studies [1], [2], [5], [7], [8]; none is estimated.
Data note. These values come from different studies, countries, populations and definitions, so this is an indirect comparison; each bar shows a point where the pathway can leak, not a ranking of steps.
Limitation. Denominators differ: eligible patients, inpatients, plan members, physicians and trial participants. None is a benchmark for a U.S. health system.
Figure data (5 rows)
| Measure | Value | Population, setting and year as reported | Source |
|---|---|---|---|
| Eligible patients referred to pulmonary rehabilitation | 40% | Eligible patients in the United Kingdom, as reported in a review of 63 studies | [5] |
| Patients with inappropriate long-acting inhaler therapy | 50% | 914 inpatients on long-acting inhalers at one large academic medical center | [1] |
| Using inhalers incorrectly at initial assessment | 39.4% | 1,876 Medicare Advantage beneficiaries with COPD in a phone-based education program | [2] |
| Physicians routinely using structured discharge summaries | 24% | Survey of 100 physicians involved in COPD care in Serbia | [8] |
| Uptake of early home-based pulmonary rehabilitation | 62% | Pilot trial of patients with exertional hypoxemia starting within one week of discharge | [7] |
Continuum of care
Where the COPD pathway breaks around discharge
Discharge after a COPD exacerbation is a high-risk transition, and routine practice often falls short of a structured handoff. In a survey of 100 physicians involved in COPD care in Serbia, 24% routinely used structured discharge summaries and 45% reported never using them.[8] Barriers included the lack of standardized templates, time constraints, poor coordination across healthcare levels and technical limitations.[8] Willingness to adopt structured discharge tools was high, with a mean score of 8.86 out of 10.[8]
Medication review before discharge offers one practical control point. A randomized trial at a large academic medical center enrolled 914 patients on long-acting inhaler therapy, and 50% were identified as having inappropriate inhaler therapy.[1] A pharmacist reviewed inhaler therapy before discharge and made recommendations where it was inappropriate by formulary preference or clinical guidelines.[1] Across all patients, time to readmission or emergency department visit did not differ significantly (hazard ratio 0.97).[1] The mean time to either event was 121 days in the intervention arm and 117 days with usual care.[1]
The COPD subgroup told a different story. Patients with COPD in the intervention arm had a lower risk of readmission or emergency department visit at 30 days (hazard ratio 0.63) and at six months (hazard ratio 0.42).[1] The authors described an opportunity for pharmacist review of both the financial and clinical appropriateness of inhaler therapy.[1] Linking that review to coverage questions puts pharmacy, case management and payer relations inside the same handoff.
Structured transitional care is also being tested for value, not only outcomes. In South Korea, 417 patients with COPD discharged from three university hospitals were assigned to transitional care services or usual care between September 2022 and September 2024.[9] A model built from the trial’s three-month outcomes found transitional care cost-effective across age cohorts and dominant in patients in their 80s.[9] The relative risks of readmission were the largest drivers of uncertainty in that model.[9]
Some interventions begin before the patient leaves. At a rural acute care hospital, a speech-language pathologist-led respiratory muscle strength training program reached 66 patients during admission.[10] The 30-day readmission rate at that hospital fell from 14.4% in 2019 to 7.3% in 2022.[10] The within-site comparison was not statistically significant, and the authors stated that causal conclusions cannot be drawn.[10]
Figure 3
Why the pathway breaks
People
- No pharmacist time to review inhaler therapy and coverage before discharge
- Physicians short of time to complete structured discharge summaries
- Professional role unclear for rehabilitation referral
Process
- Rehabilitation referral relies on clinician memory rather than a streamlined process
- Inhaler technique not checked with teach-back before discharge
- No standardized discharge template
Technology
- Technical limitations in producing discharge summaries
- No channel for remote inhaler education
- Formulary mismatch not flagged at prescribing
Environment
- Travel requirements to center-based rehabilitation
- Rural hospitals with fewer specialized services
- Growing share of deaths and care at home
Policy
- Readmission focus limited to a 30-day window
- Coverage and formulary rules that block prescribed inhalers
- Weak coordination across healthcare levels
Measurement
- Spirometry confirmation not tracked
- Results not stratified by sex, race, rurality or insurance
- Rehabilitation uptake and completion not reported
Unranked qualitative cause-and-effect diagram for the outcome in the box: Patients hospitalized for COPD return to the hospital or never reach rehabilitation, correct inhaler use and follow-up Causes are assembled from the cited literature [1], [2], [3], [4], [5], [6], [7], [8], [10], [12]; categories are not weighted and their order carries no meaning.
Data note. Qualitative; no frequencies are implied.
Limitation. Causes drawn from published studies may not all apply locally; validate them with frontline teams.
Figure data (6 rows)
| Category | Causes drawn from the cited literature |
|---|---|
| People | No pharmacist time to review inhaler therapy and coverage before discharge; Physicians short of time to complete structured discharge summaries; Professional role unclear for rehabilitation referral |
| Process | Rehabilitation referral relies on clinician memory rather than a streamlined process; Inhaler technique not checked with teach-back before discharge; No standardized discharge template |
| Technology | Technical limitations in producing discharge summaries; No channel for remote inhaler education; Formulary mismatch not flagged at prescribing |
| Environment | Travel requirements to center-based rehabilitation; Rural hospitals with fewer specialized services; Growing share of deaths and care at home |
| Policy | Readmission focus limited to a 30-day window; Coverage and formulary rules that block prescribed inhalers; Weak coordination across healthcare levels |
| Measurement | Spirometry confirmation not tracked; Results not stratified by sex, race, rurality or insurance; Rehabilitation uptake and completion not reported |
Access
Making pulmonary rehabilitation and inhaler support reachable
Pulmonary rehabilitation remains one of the clearest access gaps in COPD care. A review of 63 studies sorted the barriers and enablers to rehabilitation into a small set of domains.[5] The main ones were environment, context and resources; knowledge; social influences; professional role and identity; and memory, attention and decision making.[5] The authors saw opportunities to streamline referral processes and to target memory and decision making at the point of referral.[5]
Efforts to improve referral have shown more promise than efforts aimed at patient engagement. In that review, 54% of referral interventions and 15% of engagement interventions were rated very promising.[5] Promising engagement interventions included social support and guidance on planning and goal setting.[5] The authors also highlighted the emotional burden of living with COPD and of attending rehabilitation.[5]
Home-based programs can shorten the distance between discharge and rehabilitation. In a pilot trial, patients with exertional hypoxemia began a three-week home-based program within one week of discharge, and overall acceptance and uptake were 67% and 62%.[7] Completion was lower when high-flow nasal oxygen was added (60%) than with rehabilitation alone (89%), mainly because of reduced adherence to self-directed sessions.[7] The authors judged early home-based rehabilitation after hospitalization to be feasible and safe.[7]
Inhaler education can also reach patients without a clinic visit. A large national health plan offered phone-based teach-to-goal education to Medicare Advantage beneficiaries with COPD, and 1,876 patients were analyzed.[2] The share using inhalers incorrectly fell from 39.4% at initial assessment to 6.9% by the end of the first session.[2] Improvements appeared across different inhaler devices and subpopulations.[2]
Taken together, these studies frame access as a set of design choices: how referral is triggered, where rehabilitation is delivered and which channel carries education.[5][7] Each choice sits within executive authority, and each can be tested on a small scale before it is spread. Feasibility studies also show how to set clear tests for a pilot. The Sri Lankan rehabilitation trial defined feasibility as uptake by at least 60% of eligible participants and completion by at least 70% of those recruited.[6] In the home-based pilot, 52 of 56 patients completed follow-up at four weeks.[7] Explicit thresholds like these let a small access redesign show quickly whether it is working.
Executive guidance · System route
Build one visible operating route for COPD Awareness Month.
Use this route as a discussion framework. Replace each stage with the organization’s approved process, qualified roles, current service capacity, and applicable requirements. Do not infer a clinical protocol from the observance title.
The route at a glance
- Listen
- Clarify entry
- Coordinate the partner route
- Protect transitions
- Verify and learn
Reliability rule: Every stage needs a named owner, an observable status, an approved escalation path, and a defined signal that shows whether responsibility moved or remained unresolved.
Listen
Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions.
Clarify entry
Publish a plain-language first step and identify who receives requests through each approved channel.
Coordinate the partner route
Align internal teams and external partners around one current message, real entry point, receiving owner, escalation path, and follow-through signal.
Protect transitions
Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations.
Verify and learn
Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals.
Figure 2
The system route as one flow
The five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.
Data note. Shows sequence and handoffs only; it carries no counts or rates.
Limitation. Local processes may add, merge or reorder stages under organizational policy.
Figure data (5 rows)
| Stage | What the stage requires |
|---|---|
| Listen | Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions. |
| Clarify entry | Publish a plain-language first step and identify who receives requests through each approved channel. |
| Coordinate the partner route | Align internal teams and external partners around one current message, real entry point, receiving owner, escalation path, and follow-through signal. |
| Protect transitions | Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations. |
| Verify and learn | Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals. |
Equity and trust
Equity gaps in COPD care and outcomes
Equity in COPD care includes differences that aggregate reporting can hide. Women were a small minority of the national veterans cohort, and their pattern of care differed from that of men in both directions.[3] They were more likely to receive spirometry and tobacco cessation support but less likely to receive maintenance inhaler therapy.[3] These comparisons were adjusted for age, race and ethnicity, the Charlson Comorbidity Index and the Social Vulnerability Index.[3] The authors called for targeted strategies to ensure equitable, guideline-based care for all.[3]
Geography, sex and race also shape outcomes. In the atrial fibrillation and COPD analysis, non-metropolitan areas had higher age-adjusted mortality than metropolitan areas, and men had a higher rate (57.01) than women (34.96).[12] Non-Hispanic White individuals had a rate 2.8 times higher than Hispanic individuals.[12] The analysis of COPD and Alzheimer’s disease likewise reported significant disparities by sex, race and urbanization status.[13]
Social conditions appear in prevalence data as well. Insurance status, income and educational attainment were independent predictors of coexisting coronary heart disease and COPD, alongside race and ethnicity and geographic region.[15] For COPD and obesity, mortality varied across racial and ethnic groups, urbanization levels, regions and states.[14] Those authors pointed to integrated care and improved access in underserved communities.[14]
Culturally adapted services offer one route to closing access gaps. In Colombo, Sri Lanka, a trial tested culturally adapted pulmonary rehabilitation with 50 adults with COPD.[6] Seventy-nine eligible individuals, 94% of those screened, were referred to recruit them, an uptake of 63%.[6] The program added nutritional support and group singing, and 72% of intervention participants completed the study, compared with 64% of the control group.[6] Participants described dispelled misbeliefs about COPD and better medication adherence, while travel requirements remained a challenge.[6]
Rural hospitals can host promising services too. The respiratory muscle training pilot took place at a rural acute care hospital, and its authors called for further prospective study, particularly in rural settings.[10] Stratifying local COPD measures by sex, race, ethnicity, rurality and insurance lets leaders see whether improvements reach the groups these studies identify. Without that view, an average gain can mask a widening gap.
Human infrastructure
The roles that hold COPD pathways together
COPD pathways depend on roles that rarely share one organizational chart. Pharmacists, respiratory therapists, rehabilitation staff, nurses, educators, speech-language pathologists and hospital physicians each carry part of the work. Recent studies show that several of these roles can own a defined piece of the handoff when their scope is clear.[1][10]
Pharmacists can close a gap that blends clinical and financial review. In the inhaler trial, half of the patients on long-acting therapy had regimens judged inappropriate based on formulary preference or clinical guidelines.[1] The trial population was mixed, with 56% of patients having COPD and 33% asthma.[1] Doing that review before discharge requires pharmacist time on inpatient units and a reliable route for recommendations to reach prescribers.
Speech-language pathologists are an underused resource in some hospitals. The rural pilot noted that respiratory muscle weakness and dysphagia are common in COPD, and the training was well tolerated with no reported adverse events.[10] The authors described the program as feasible and cost-effective, while calling for prospective study of it as an interdisciplinary intervention.[10] Readmission rates in 2022 were also significantly lower than those at a comparable hospital in the same system that did not run the program.[10] Health plans can extend the workforce as well, since the teach-to-goal inhaler program was delivered by phone through a large national plan.[2]
Physicians recognize the drivers of readmission but often lack time and tools. In the Serbian survey, physicians most often named active smoking (90%), poor treatment adherence (81%), comorbidities (77%) and incorrect inhaler technique (72%) as contributors to 30-day readmissions.[8] Time constraints and poor coordination across care levels were among the barriers to structured discharge summaries.[8] Transitional care staffing carries a cost that boards will ask about. In the Korean model, the cost of the transitional care intervention was one of the influential parameters.[9]
Organizational structure may matter as well. In a matched comparison of 200 hospitals in each group, hospitals with more than 50% employed physicians had better COPD mortality scores (-0.38).[11] The authors suggested this likely reflects a broader organizational phenotype of alignment, scale and clinical integration rather than employment as an isolated strategy.[11] Rehabilitation referral faces its own workforce question, since professional role and identity was one of the main barrier domains in the review of 63 studies.[5]
Executive guidance · Operating dashboard
Use a small dashboard to expose friction and ownership.
Do not publish a number until the organization defines its numerator, denominator where relevant, owner, source system, exclusions, review cadence, and limits. The candidates below are management prompts, not benchmarks or reported results.
Four operating signals
Each signal pairs an executive question with one candidate local measure, set out below.
Executive guidance · Signal
Entry-point clarity
Can people and staff identify the approved first step without searching across conflicting instructions?
- Candidate local measure
- Locally defined contact, routing, and repeat-contact signals by channel and service.
Executive guidance · Signal
Ownership reliability
Does a specific team accept each request and make its status visible?
- Candidate local measure
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
Executive guidance · Signal
Partner-route reliability
Do participating teams share one current route and understand who owns each dependency?
- Candidate local measure
- Locally defined conflicting instructions, unaccepted handoffs, unresolved dependencies, repeat contacts, and partner feedback.
Executive guidance · Signal
Improvement closure
Does the organization correct recurring friction and report what changed?
- Candidate local measure
- Selected barriers, assigned actions, completion status, and post-change review.
Figure 4
The operating system behind the dashboard
The four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.
Data note. Structural diagram; no measured values.
Limitation. Owners are candidates to be confirmed locally.
Figure data (4 rows)
| Operating signal | Candidate owner |
|---|---|
| Entry-point clarity | Executive sponsor and operational lead |
| Ownership reliability | Operational owner and participating teams |
| Partner-route reliability | Sending and receiving owners |
| Improvement closure | Improvement owner and executive sponsor |
Executive guidance · Handoff workflow
Close the loop across teams, settings, and partners.
A handoff is reliable only when the sending party knows who is expected to receive the work, the receiving party acknowledges responsibility, and any unresolved exception remains visible. Local policy and qualified judgment control the actual process.
How responsibility moves
Lane A
From message to accepted ownership
- Confirm the approved message and intended audience.
- Publish the actual entry point and receiving role.
- Acknowledge receipt using the locally approved method.
- Escalate when ownership or response remains unclear.
Lane B
From accepted ownership to verified follow-through
- Record the next accountable owner and visible status.
- Name the sending and receiving owners, shared information, current status, and unresolved dependency.
- Keep unresolved work visible across boundaries.
- Confirm closure or document the continuing exception.
Executive guidance · Executive scorecard
Give leaders one view of route reliability and improvement.
The scorecard keeps review focused on decisions. Leaders should set definitions locally, examine variation without overclaiming cause, and pair quantitative signals with the experience of people who use and operate the route.
Who reviews what
- Executive sponsor and operational lead
- Operational owner and participating teams
- Sending and receiving owners
- Improvement owner and executive sponsor
Candidate owners named in the scorecard, confirmed locally.
| Operating signal | Executive question | Candidate owner | Suggested review point |
|---|---|---|---|
| Entry-point clarity | Can people and staff identify the approved first step without searching across conflicting instructions? | Executive sponsor and operational lead | At campaign launch and close |
| Ownership reliability | Does a specific team accept each request and make its status visible? | Operational owner and participating teams | At a locally defined cadence |
| Partner-route reliability | Do participating teams share one current route and understand who owns each dependency? | Sending and receiving owners | At a locally defined cadence |
| Improvement closure | Does the organization correct recurring friction and report what changed? | Improvement owner and executive sponsor | Until action is verified |
Figure 5
Control points for a reliable COPD care pathway
| Control point | Risk if missing | Owner | Evidence of control |
|---|---|---|---|
| Spirometry confirmation for COPD diagnoses | Patients are treated or left untreated on an unconfirmed label, with differences by sex | Primary care medical director with pulmonary function laboratory lead | Share of COPD diagnoses with confirmatory spirometry, stratified by sex and race |
| Pharmacist inhaler and coverage review before discharge | Inappropriate or uncovered inhaler therapy at home | Director of pharmacy and hospital medicine lead | Share of COPD discharges with a documented pharmacist review |
| Inhaler technique education with teach-to-goal | Incorrect technique persists after discharge | Respiratory care manager and patient education lead | Share of patients with technique checked and correct at last session |
| Structured discharge summary sent to the next clinician | Next clinician lacks the plan and readmission risks | Chief medical officer and transitions of care lead | Share of COPD discharges with a structured summary received |
| Default pulmonary rehabilitation referral with home-based option | Few eligible patients are referred or start | Rehabilitation program manager and pulmonary lead | Referral, start and completion rates by setting |
| Readmission review through one year with equity stratification | Late readmissions and disparities stay invisible | Quality officer and board quality committee | Readmission at 30, 90, 180 and 365 days by sex, race, rurality and insurance |
Control points derived from the cited evidence [1], [2], [3], [4], [5], [7], [8] and this brief’s executive guidance.
Data note. Each row is a control to verify, not a measured result.
Limitation. Owners and evidence of control must follow local policy and applicable requirements.
Public communication
Communicating COPD care so people can act on it
Communication in COPD care is often hands-on, because correct inhaler use depends on demonstration and feedback. The phone-based teach-to-goal program measured technique with validated checklists alongside patient self-report.[2] Its authors judged that the multiple-session approach was likely critical for longer-term retention of correct technique, while noting that this needs further study.[2] They also found that some subgroups were at greater risk of misuse, which calls for tailoring rather than a single script.[2]
Communication between care settings matters as much as communication with patients. Physicians in the discharge survey reported gaps between recommended and routine practice and listed poor coordination across healthcare levels as a barrier.[8] A structured discharge summary is a message to the next clinician, and only 24% of respondents used one routinely.[8]
Patients’ own accounts show which messages land. In the Sri Lankan focus groups, participants described increased knowledge, improved walking ability, reduced breathlessness and enjoyment of the cultural adaptations.[6] In the home-based pilot, participants valued receiving care and education at home but reported challenges with oxygen equipment during unsupervised exercise.[7] Sri Lankan participants also named adherence to exercise and travel requirements as challenges.[6]
Population data need careful framing in public messages. The obesity analysis described an apparent obesity paradox, in which obesity has been associated with lower mortality in some patients with COPD.[14] Its authors noted that individual factors such as smoking, COPD severity and socioeconomic characteristics were unavailable.[14] Messages that cite trend data should carry the same caution and avoid implying individual risk. Trust also depends on acknowledging what patients feel. The rehabilitation review highlighted the emotional burden of COPD and of attending rehabilitation, and it listed knowledge and beliefs about capabilities among the domains shaping engagement.[5] Social influences and emotions were also highly represented for patient engagement.[5] Public messages during COPD Awareness Month can describe rehabilitation, inhaler support and follow-up in plain terms. They work best when they point to a route the organization has actually staffed.
Leaders communicate through what they measure and report as well. Because pooled readmission rates keep rising through the first year after discharge, a report limited to 30-day rates may understate what patients experience.[4] Economic results deserve the same care: the Korean model estimated probabilities of cost-effectiveness of 55.7%, 67.9% and 82.7% across the three age cohorts.[9] Those probabilities belong in board reports alongside the headline finding.
Executive guidance · 90-day plan
Turn the observance into one sustained operating change.
The time boxes below are a management framework, not a clinical timeline. Adjust them to risk, scope, governance, resources, stakeholder participation, and applicable review requirements.
Ninety days, three moves
- Days 1–30See the current route
- Days 31–60Build the reliable path
- Days 61–90Make the change visible
Days 1–30 · Listen and map
See the current route
- Name an executive sponsor and an operational owner.
- Listen to people using the route and representative frontline teams.
- Map how COPD Awareness Month communications connect to real entry points, owners, transitions, and escalation.
- Select one recurring barrier that the organization can responsibly address.
Days 31–60 · Design and test
Build the reliable path
- Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
- Validate the design with every sending and receiving team involved.
- Test one internal or partner handoff and correct a verified communication, dependency, or ownership gap.
- Test the route in more than one representative setting or operating period where practical.
Days 61–90 · Implement and verify
Make the change visible
- Launch the redesigned route with a small set of locally defined measures.
- Review unresolved work and recurring friction using a learning approach.
- Correct implementation barriers and record who owns each remaining dependency.
- Report what changed, what evidence was reviewed, and what still requires live oversight.
Figure 6
The 90-day plan on one timeline
The 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.
Data note. Time boxes are a management framework, not a clinical timeline.
Limitation. Durations are uniform 30-day windows; real tasks may span windows.
Figure data (12 rows)
| Window | Action |
|---|---|
| Days 1–30 · Listen and map | Name an executive sponsor and an operational owner. |
| Days 1–30 · Listen and map | Listen to people using the route and representative frontline teams. |
| Days 1–30 · Listen and map | Map how COPD Awareness Month communications connect to real entry points, owners, transitions, and escalation. |
| Days 1–30 · Listen and map | Select one recurring barrier that the organization can responsibly address. |
| Days 31–60 · Design and test | Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal. |
| Days 31–60 · Design and test | Validate the design with every sending and receiving team involved. |
| Days 31–60 · Design and test | Test one internal or partner handoff and correct a verified communication, dependency, or ownership gap. |
| Days 31–60 · Design and test | Test the route in more than one representative setting or operating period where practical. |
| Days 61–90 · Implement and verify | Launch the redesigned route with a small set of locally defined measures. |
| Days 61–90 · Implement and verify | Review unresolved work and recurring friction using a learning approach. |
| Days 61–90 · Implement and verify | Correct implementation barriers and record who owns each remaining dependency. |
| Days 61–90 · Implement and verify | Report what changed, what evidence was reviewed, and what still requires live oversight. |
Executive guidance · Leadership close
Make COPD Awareness Month a starting point, not an endpoint.
Recognition matters. It becomes durable when leaders also listen, clarify the route, support the people operating it, close an identified gap, and report the result without claiming more than the evidence supports.
Leadership commitment
Make ownership visible, test the route, and report what improved.
Executive action kit · Month observance
Turn COPD Awareness Month into accountable action.
A practical executive framework for access, ownership, handoffs, measurement, and improvement.
Leadership focus
Use this observance to examine trustworthy information, prevention access, and community connection. Select one verified barrier, assign an accountable owner, and carry the improvement beyond the campaign window.
Workforce lens
Ask whether staffing, role clarity, training, tools, workload, and escalation support the people operating the information, access, coordination, and follow-through pathway.
Patient and community lens
Make the approved first step clear. Test whether a person can move from information to an acknowledged next action without navigating conflicting instructions.
Equity and access lens
Review language, disability, transportation, digital access, geography, trust, and other barriers using protected feedback and locally appropriate data.
Five-minute briefing
Inspect the operating sequence
Listen with people using the pathway, frontline teams, operational leaders, and community partners. Find one a message, request, referral, or handoff that does not reach an accountable owner, then test the locally approved route from entry through acknowledged follow-through.
- Listen
- Clarify entry
- Coordinate the partner route
- Protect transitions
- Verify and learn
Leadership actions for this week
- Name an executive sponsor and frontline operating owner.
- Ask people using and operating the pathway where ownership becomes unclear.
- Test one representative route from first question to acknowledged next step.
- Select one barrier that can be corrected without overstating the evidence.
- Set a review date and define how completion will be verified.
Candidate measures
Define every numerator, denominator where relevant, owner, data source, exclusions, cadence, and limitation locally. These are management prompts, not external benchmarks.
- Locally defined contact, routing, and repeat-contact signals by channel and service.
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
- Locally defined conflicting instructions, unaccepted handoffs, unresolved dependencies, repeat contacts, and partner feedback.
Department readiness checklist
- The public and staff entry points match the actual approved process.
- A specific role accepts each request, referral, or escalation.
- Handoffs include acknowledgment and a visible unresolved state.
- Language, disability, digital, transportation, and trust barriers receive explicit review.
- Communications do not introduce unsupported themes, statistics, or clinical advice.
- A named leader will review what changed after the observance.
Intended audiences
- Executive and Operational Leaders
- Public Health and Community Partners
Staff communication template
During COPD Awareness Month, our organization will connect awareness with a practical review of the information, access, coordination, and follow-through pathway. Use approved information, identify the correct entry point, confirm ownership when work moves, protect privacy, and escalate unresolved barriers through local channels.
Community communication template
COPD Awareness Month is an opportunity to share trustworthy information and make the next step easier to find. Use our approved channels for information and support. If a request changes hands, our goal is to keep ownership and follow-through visible.
Measurement worksheet
- Signal
- What observable condition will show whether the route works?
- Definition
- What is included, excluded, and counted?
- Owner
- Who reviews the signal and acts on exceptions?
- Cadence
- When will leaders review it?
- Equity check
- Which differences require protected, locally appropriate review?
- Closure
- What evidence will confirm the improvement was completed?
- Editorial review
- Completed
- Source records
- 2 listed under Authoritative resources
- Review standard
- Sourced facts remain separated from original executive guidance
- Clinical boundary
- No new statistical or clinical claim was added by this action kit
Sources and content boundary
Authoritative resources
Use note: All operating models, measures, scorecard questions, and action steps are original executive guidance. This article supports leadership planning and education. It does not replace clinical judgment, emergency procedures, legal advice, professional standards, organizational policy, or applicable federal, state, and local requirements.
Peer-reviewed references
References
Fifteen peer-reviewed sources, newest first. Each was individually verified through authenticated academic research databases. Bracketed numbers in the text link here; the original executive guidance on this page carries no citations because it is guidance, not a sourced claim. Sources last checked in those databases on .
- 1.Parrott TD, Wallace MD, Eble SH, Niehoff KM, Gao Y, Choi L, et al. A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmission (PILLAR). CHEST Pulmonary. 2026;4(2):100231. https://doi.org/10.1016/j.chpulm.2025.100231
- 2.Press VG, Katsikas A, Swankoski K, Boudreau E, Thomas E. Phone-Based Teach-To-Goal Inhaler Education Program for Medicare Advantage Beneficiaries With COPD. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation. 2026;13(2):84-92. https://doi.org/10.15326/jcopdf.2025.0667
- 3.Hamann KM, Wendt CH, Baldomero AK. Sex differences in delivery of guideline-recommended COPD care: A national U.S. cohort. Respiratory Medicine. 2026;263:109196. https://doi.org/10.1016/j.rmed.2026.109196
- 4.Tian H, Shen W, Huang L, Feng B, Hong B, Li X, et al. Risk factors for hospital readmission in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Frontiers in Medicine. 2026;13:1836031. https://doi.org/10.3389/fmed.2026.1836031
- 5.Moore A, Reardon I, Ramkissoon O, Early F, Payerne E, Ashford PA, et al. Referral to and Engagement with Pulmonary Rehabilitation: A Review and Strategic Behavioural Analysis of Factors Influencing Behaviour and Intervention Opportunities. International Journal of Chronic Obstructive Pulmonary Disease. 2026;21:1-29. https://doi.org/10.2147/copd.s558338
- 6.Jayamaha A, Perera C, Orme M, Karunatillake R, Fernando A, Barton A, et al. The Feasibility and Acceptability of Culturally Appropriate Pulmonary Rehabilitation for Adults with Chronic Obstructive Pulmonary Disease in Sri Lanka: Randomized Controlled Trial. International Journal of Chronic Obstructive Pulmonary Disease. 2026;21:1-16. https://doi.org/10.2147/copd.s527013
- 7.Mok Y, Foong JW, Wong HS, Shih‐Yen EC, Hassan N, Klainin‐Yobas P, et al. High‐Flow Nasal Oxygen in Early Home Pulmonary Rehabilitation for Exertional Hypoxaemia: A Pilot Randomised Feasibility Trial. Respirology. 2026;31(10):1029-1040. https://doi.org/10.1002/resp.70277
- 8.Dimic-Janjic S, Stjepanovic M, Cekerevac I, Hromis S, Buha I, Cupurdija V, et al. Discharge Practices After Hospitalization for COPD Exacerbations: A Physician Survey and SWOT Analysis. Healthcare. 2026;14(12):1786. https://doi.org/10.3390/healthcare14121786
- 9.Hwang YS, Kim DK, Lee JK, Heo EY, Lee HW, Kim SK, et al. Transitional care services are cost-effective for older patients with chronic obstructive pulmonary disease in Korea. International Journal for Quality in Health Care. 2026;38(4):mzag136. https://doi.org/10.1093/intqhc/mzag136
- 10.Vora J, Morey S. Impact of Respiratory Muscle Strength Training Program on Hospital Readmissions in Patients With Chronic Obstructive Pulmonary Disease: A Retrospective Pilot Study. American Journal of Speech-Language Pathology. 2026;35(5):2364-2377. https://doi.org/10.1044/2026_ajslp-25-00613
- 11.Green S, Hamadi H, Zhao M, Spaulding A. Physician employment and hospital readmission and mortality outcomes: an organizational perspective. Journal of Health Organization and Management. 2026:1-12. https://doi.org/10.1108/jhom-02-2026-0209
- 12.Zheng XB, Yao BQ, Zhang M, Hou SX, Wu HY. Mortality trends and disparities in older U.S. adults with atrial fibrillation and COPD: a 1999–2020 CDC WONDER analysis with forecast to 2030. Frontiers in Cardiovascular Medicine. 2026;13:1811188. https://doi.org/10.3389/fcvm.2026.1811188
- 13.Ahmad M, Irshad A, Ahmed MA, Ahmed FK, Noor S, Irshad H. Demographic, gender and ethnic disparities in COPD associated mortality trends among older adults (>55 years) with Alzheimer’s disease in the United States, 1999–2020: a 20 year retrospective analysis using CDC WONDER database. Journal of the National Medical Association. 2026;118(5):947-958. https://doi.org/10.1016/j.jnma.2026.06.021
- 14.Khan AA, Hussain SA, Ahmad ZB, Ali R, Aminpoor H, Hanif L, et al. Trends in mortality involving chronic obstructive pulmonary disease and obesity in the United States, 1999–2023. Medicine. 2026;105(40):e50980. https://doi.org/10.1097/md.0000000000050980
- 15.Idris MA, Valenzuela VM, Aguilera J. Coronary heart disease and chronic obstructive pulmonary disease prevalence and temporal trends among United States adults: a national population-based study. Frontiers in Epidemiology. 2026;6:1840095. https://doi.org/10.3389/fepid.2026.1840095
Claim-to-source matrix
What each source supports
Every sourced claim in the new sections maps to the references that support it, the section where it is used, and the limitation a reader should keep in mind. Original executive guidance carries no sources because it is guidance, not a finding.
| Claim group | Sources | Years | Used in | Limitation |
|---|---|---|---|---|
| Mortality trends for COPD with atrial fibrillation, Alzheimer’s disease and obesity | [12] [13] [14] | 2026 | Current evidence | Death-certificate analyses of U.S. populations; associations only, no individual-level smoking or severity data. |
| Coexisting coronary heart disease and COPD prevalence and predictors | [15] | 2026 | Current evidence | Cross-sectional national survey, 2020 to 2024; self-reported conditions. |
| Sex differences in spirometry, inhaler and tobacco cessation care | [3] | 2026 | Equity and trust | Veterans health system cohort with few women; coded encounters may miss care delivered elsewhere. |
| COPD readmission rates over one year and associated factors | [4] | 2026 | Current evidence | Pooled observational studies with varied settings and definitions. |
| Structured discharge practice and physician-perceived readmission drivers | [8] | 2026 | Continuum of care | Exploratory self-reported survey of 100 physicians in one country. |
| Pharmacist inhaler review before discharge | [1] | 2026 | Continuum of care | Single-center trial; benefit seen in the COPD subgroup, not the overall population. |
| Cost-effectiveness of transitional care services | [9] | 2026 | Continuum of care | Markov model built on three-month trial outcomes in South Korea; long-term effects modeled, not observed. |
| In-hospital respiratory muscle training led by speech-language pathologists | [10] | 2026 | Human infrastructure | Retrospective pilot at one rural hospital; within-site change not statistically significant. |
| Barriers to pulmonary rehabilitation referral and engagement | [5] | 2026 | Access | Review of 63 studies; promise ratings based on behavior change, not clinical outcomes. |
| Early home-based pulmonary rehabilitation after discharge | [7] | 2026 | Access | Small pilot feasibility trial across respiratory conditions. |
| Culturally adapted pulmonary rehabilitation | [6] | 2026 | Equity and trust | Feasibility trial of 50 adults in one city; not powered for clinical outcomes. |
| Phone-based teach-to-goal inhaler education | [2] | 2026 | Public communication | Single health plan program without a concurrent control group. |
| Physician employment and hospital COPD mortality scores | [11] | 2026 | Human infrastructure | Cross-sectional matched comparison of 2021 hospital data; association, not causation. |
About the author
Greg Wahlstrom
MBAHCM
President and Chief Executive Officer, The Healthcare Executive
View Greg’s profile©2014 – 2026 The Healthcare Executive. All rights reserved.